NFKB1 and Miyoshi myopathy: Another beneficial inhibitory NF-κB effect of BTZ may be its ability to downregulation of adhesion molecule ICAM-1 and IL-6 secretion from bone marrow stromal cells (BMSCs) that are known to increase proliferation, survival, and drug resistance in MM cells [168].